GE HealthCare Technologies (GEHC) EPS (Weighted Average and Diluted) (2022 - 2026)

GE HealthCare Technologies has reported EPS (Weighted Average and Diluted) for 5 years, with the latest figure at $0.85 in Q1 2026.

• For the quarter ending Q1 2026, EPS (Weighted Average and Diluted) fell 30.89% year-over-year to $0.85; the trailing twelve-month figure through Mar 2026 stood at $4.18 (down 12.0% YoY), and the FY2025 full-year result was $4.55, up 4.84% from the prior year.
• EPS (Weighted Average and Diluted) for Q1 2026 stood at $0.85, down from $1.29 in the prior quarter.
• The five-year high for EPS (Weighted Average and Diluted) was $1.57 in Q4 2024, with the low at $0.41 in Q1 2023.
• Historically, EPS (Weighted Average and Diluted) has averaged $1.0 across 5 years, with a median of $0.98 in 2025.
• Annual changes were most pronounced in 2023 — EPS (Weighted Average and Diluted) slumped 52.33% — and 2024, when it surged 97.56%.
• GE HealthCare Technologies' EPS (Weighted Average and Diluted) stood at $1.22 in 2022, then declined by 27.05% to $0.89 in 2023, then surged by 76.4% to $1.57 in 2024, then slipped by 17.83% to $1.29 in 2025, then slumped by 34.11% to $0.85 in 2026.
• The last three EPS (Weighted Average and Diluted) figures came in at $0.85 (Q1 2026), $1.29 (Q4 2025), and $0.98 (Q3 2025), per Business Quant data.